candesartan cilexetil and hydrochlorothiazide

Product NDC
68382-194
11-digit product format
683820194
Labeler code
68382
Product ID
68382-194_7750ee73-dc70-452f-87f1-f38216254e35
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
candesartan cilexetil and hydrochlorothiazide
Dosage form
TABLET
Route
ORAL
Labeler
Zydus Pharmaceuticals USA Inc.
Application
ANDA203466
Marketing category
ANDA
Marketing start
2018-04-14
Marketing end
0000-00-00
Substance
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
Active strength
16 mg/1; mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
68382-194-0168382019401100 TABLET in 1 BOTTLE (68382-194-01) 100 tablet2018-04-140000-00-00NoNoCurrent
68382-194-066838201940630 TABLET in 1 BOTTLE (68382-194-06) 30 tablet2018-04-140000-00-00NoNoCurrent
68382-194-10683820194101000 TABLET in 1 BOTTLE (68382-194-10) 1000 tablet2018-04-140000-00-00NoNoCurrent
68382-194-166838201941690 TABLET in 1 BOTTLE (68382-194-16) 90 tablet2018-04-140000-00-00NoNoCurrent
68382-194-776838201947710 BLISTER PACK in 1 CARTON (68382-194-77) > 10 TABLET in 1 BLISTER PACK10 blister pack2018-04-140000-00-00NoNoCurrent